ReviewCurrent opinion in psychiatry2020
Introducing the National Drug Early Warning System.
Review in Current opinion in psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Surveillance of emerging drug trends: utilizing the National Drug Early Warning System.Current opinion in psychiatry · 2026Review
- "Anything can happen": experiences of people using opioids in a xylazine market.Harm reduction journal · 2025Article
- Pharmacovigilance-related events, disease burden and overall efficiency of care in european countries, 1990-2021.Frontiers in pharmacology · 2025Article
- Co-design of the Australian Prompt Response Network for a public-health focused intersectoral approach to information sharing on emerging drugs of concern.Frontiers in public health · 2025Article
- Exploring unregulated substance use health data in Ontario, Canada: Identifying gaps, addressing challenges, and uncovering opportunities.Frontiers in public health · 2025Article
- Syringe services program staff and participant perspectives on changing drug consumption behaviors in response to xylazine adulteration.Harm reduction journal · 2024Article
- Protective or potentially harmful? Altering drug consumption behaviors in response to xylazine adulteration.Research square · 2024Article
- Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia.Harm reduction journal · 2023Article
- 'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alerts.Harm reduction journal · 2023Article
- Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20.Addiction (Abingdon, England) · 2022Article
- Nobody Wants to Be Narcan'd: A Pilot Qualitative Analysis of Drug Users' Perspectives on Naloxone.The western journal of emergency medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
purpose of reviewIn 2013, NIH NIDA released a special funding opportunity to update and expand their longstanding Community Epidemiology Workgroup (CEWG) by creating a coordinating center for a new type of monitoring system that became the National Drug Early Warning System (NDEWS). This article provides an overview of four primary NDEWS components: core staff; an approach to detecting and monitoring emerging drug trends including community-based epidemiologists and national databases; small rapid follow-up studies; and innovative multimedia approaches for disseminating information. RECENT
findingsThe cornerstones for detecting and monitoring are the 1700+ member NDEWS Network and a coalition of local epidemiologists. Follow-up studies are designed with local researchers, practitioners, and policymakers to focus on local trends. Among NDEWS accomplishments are developing protocols for expanded urinalyses in high-risk populations and conducting follow-up studies with local collaborators in New Hampshire, New York, Ohio, Oregon, and a tribal nation in Minnesota. SUMMARY: During its first 6 years, NDEWS has advanced its mission to develop multidisciplinary collaborations and innovative technologies for identifying, monitoring, and following up on emerging drug trends and has contributed to the translation of science into practice. VIDEO ABSTRACT: http://links.lww.com/YCO/A55.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.